Myelodysplastic Syndrome/AML Risk Increased After Chemo

FRIDAY, Jan. 4, 2019 -- The risks for therapy-related myelodysplastic syndrome or acute myeloid leukemia (tMDS/AML) are elevated after chemotherapy use for solid tumors, according to a study published online Dec. 20 in JAMA Oncology. Lindsay M....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news